$14.18 Million in Sales Expected for Ocular Therapeutix, Inc. (NASDAQ:OCUL) This Quarter
Equities research analysts predict that Ocular Therapeutix, Inc. (NASDAQ:OCUL) will report $14.18 million in sales for the current fiscal quarter, Zacks Investment Research reports. Four analysts have made estimates for Ocular Therapeutix’s earnings. The highest […]
